Constructing, Validating and Updating Machine Learning Models to Predict Survival in Children with Ebola Virus Disease

Although case fatality rates remain high, there are limited data on predicting mortality in children with Ebola Virus Disease (EVD). Furthermore, challenges in predicting EVD outcomes using clinical and laboratory data highlight the need for the development and validation of pediatric predictive models. The novel EVD Prognosis in Children (EPiC) model uses clinical and biochemical information, such as aminotransferase (AST) and creatinine kinase (CK), to predict mortality in infected children. While few prognostic models or scoring systems have been developed to predict clinical outcomes of EVD, the majority of them were limited in geographical and temporal scope having been derived using data from one location. As such, the EPiC model is the first externally validated model for the prognosis of pediatric EVD using diverse datasets from geographically and temporally separate outbreaks. This model can be easily applied by bedside clinicians to assess pediatric patients at risk for death and help to allocate resources accordingly.

Start Date:2020

End Date:2022

Partners: Brown University
University of Massachusetts
University of Georgia
University of Connecticut School of Medicine
Liberia Ministry of Health

Donors: National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Rhode Island Foundation

Publications: PLOS Neglected Tropical Diseases